Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP876881.RABNqPtkv4ZIpPrUMVwdzgo6WTaW7bFcA6Xgm1gcEvbn4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP876881.RABNqPtkv4ZIpPrUMVwdzgo6WTaW7bFcA6Xgm1gcEvbn4130_assertion type Assertion NP876881.RABNqPtkv4ZIpPrUMVwdzgo6WTaW7bFcA6Xgm1gcEvbn4130_head.
- NP876881.RABNqPtkv4ZIpPrUMVwdzgo6WTaW7bFcA6Xgm1gcEvbn4130_assertion description "[Our results indicate sustained virological response causes a two-thirds reduction in the risk of type 2 diabetes development in HCV-positive patients treated with IFN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP876881.RABNqPtkv4ZIpPrUMVwdzgo6WTaW7bFcA6Xgm1gcEvbn4130_provenance.
- NP876881.RABNqPtkv4ZIpPrUMVwdzgo6WTaW7bFcA6Xgm1gcEvbn4130_assertion evidence source_evidence_literature NP876881.RABNqPtkv4ZIpPrUMVwdzgo6WTaW7bFcA6Xgm1gcEvbn4130_provenance.
- NP876881.RABNqPtkv4ZIpPrUMVwdzgo6WTaW7bFcA6Xgm1gcEvbn4130_assertion SIO_000772 19127513 NP876881.RABNqPtkv4ZIpPrUMVwdzgo6WTaW7bFcA6Xgm1gcEvbn4130_provenance.
- NP876881.RABNqPtkv4ZIpPrUMVwdzgo6WTaW7bFcA6Xgm1gcEvbn4130_assertion wasDerivedFrom befree-20140225 NP876881.RABNqPtkv4ZIpPrUMVwdzgo6WTaW7bFcA6Xgm1gcEvbn4130_provenance.
- NP876881.RABNqPtkv4ZIpPrUMVwdzgo6WTaW7bFcA6Xgm1gcEvbn4130_assertion wasGeneratedBy ECO_0000203 NP876881.RABNqPtkv4ZIpPrUMVwdzgo6WTaW7bFcA6Xgm1gcEvbn4130_provenance.